HomeFUNDING

Category: FUNDING

Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.

Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.

AISAP Raises $13 Million in...

May 2, 2024

"Obtaining an accurate ultrasound diagnosis in time can literally be the difference between life and death, so the fact that so many patients are forced to wait up to a month for one is nothing short of a global health crisis," says AISAP CEO Roni Attali. "This problem is particularly acute in rural areas or those with fewer resources, and therefore disproportionately impacts disadvantaged populations."

Vitestro Secures $22 Million (€20...

April 30, 2024

Co-led by return investor Sonder Capital and new investor NYBC Ventures, with participation from Invest-NL, the European Innovation Council Fund (EIC Fund), and existing private investors, the oversubscribed funding round will support Vitestro’s commercialization in Europe and its organizational expansion into the U.S. market.

AISAP Raises $13 Million in Seed Funding for First AI-Powered, Point Of Care Ultrasound Diagnostic Solution

May 2, 2024

Pacific6 Enterprises and JM Molina Investments Announce a Joint Investment in Detact Diagnostics

Pacific6 is an investment partnership founded, in part, by John Molina, the former CFO of Molina Healthcare. His brother, J. Mario Molina, M.D., former CEO of Molina Healthcare, is the principal behind JM Molina Investments.

December 17, 2020

Senecio Robotics Awarded $12 Million

With nearly 700 million people infected with a mosquito-borne disease every year, as well as the increase in mosquito populations driven by a warming climate, it is a massive and growing challenge to fight them using only traditional approaches.

December 15, 2020

osteolabs GmbH Successfully Closes Second Financing Round of Nearly 1.6 Million EUR

The funds raised will be used to promote the further geographical expansion of osteolabs GmbH in the Scandinavian countries, the BENELUX countries, Switzerland and Austria.

December 8, 2020

Basking Biosciences Completes $5.4M Seed Financing: Funds to Support Development of the 1st Reversible Thrombolytic Therapy for Acute Ischemic Stroke

The investor syndicate includes Rev1 Ventures, Broadview Ventures, and Viva BioInnovator. Concurrent with the financing, Ryan Helon of Rev1, Thomas Needham of Broadview, and Dr. Dan Meyers have joined Basking’s Board of Directors.

December 7, 2020

Fusion Antibodies and Queen’s University Belfast Awarded a £453,000 Grant from Invest Northern Ireland

The two organisations will use the funds to accelerate the discovery of novel therapeutic and diagnostic antibodies with validated anti-infective properties against COVID-19. Building on strong scientific knowhow, a new antibody development platform will be created that will help realise the vision of producing a breakthrough therapeutic that directly targets SARS-CoV-2.

December 3, 2020

Kayentis, a global provider of digital data capture systems for clinical trials, today announces it has raised €7M (approx. $8.3M) in growth capital.

Kayentis is active in the global electronic Clinical Outcome Assessment (eCOA) market, which is expected to reach $2.6 billion by 2027. Market growth in eCOA – a method of capturing outcomes data electronically in clinical trials – is driven by the clinical trials industry.

December 2, 2020

MapLight Therapeutics Receives $8.1 Million For Parkinson’s Disease Research

To undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering psychiatric symptoms in Parkinson's disease.

November 30, 2020

Eluminex Biosciences Announces Closing of $50 Million Series A Financing

Eluminex also announced that Charles Semba, MD, has joined Eluminex as Chief Medical Officer

November 27, 2020

Ginkgo Bioworks Announces U.S. International Development Finance Corporation Approved a Loan of Up to $1.1 billion

"DFC is proud to support this American company in the fight against COVID-19," said DFC Chief Executive Officer Adam Boehler. "Ginkgo is working to provide Americans with needed testing capacity and vaccine supplies which will facilitate our recovery from this global pandemic."

November 25, 2020